Sort
78,016 grants matching “breast cancer”
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$712,992Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$712,992Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors
$712,969Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Ontario Familial Breast Cancer Registry
$712,896Irene L. Andrulis · Cancer Care Ontario · U01 · FY2008 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$712,796Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$712,796Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
ROLE OF RUNX1 REARRANGEMENTS IN TRIPLE-NEGATIVE BREAST CANCER PROGRESSION AND IMMUNE EVASION
$712,770University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2022 · Department of the Army
CANCER PREVENTION AND CONTROL TRAINING GRANT
$712,733University Of Arizona · R25 · FY2001 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$712,726Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Protein Tyrosine Dephosphorylation & Signal Transduction
$712,640Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2010 · CA
Radiomic and genomic predictors of breast cancer risk
$712,593Weiva Sieh · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
MODELING BREAST DEVELOPMENT AND CANCER IN A NOVEL ANIMAL MODEL
$712,535University Of California, Davis · · FY2010 · Department of the Army
Development of Best-in-Class Pol-Theta Inhibitors
$712,514Richard T Pomerantz · Thomas Jefferson University · R01 · FY2024 · CA
The impact of lifestyle and genetic factors on mammographic density in a cohort of Hispanic women
$712,453Sara Lindstroem · University Of Washington · R01 · FY2022 · CA
Cherokee Nation Native American Research Center for Health
$712,440Sohail Imran Khan · Cherokee Nation · S06 · FY2018 · GM
Upright, Low-dose, High-resolution, 3D Breast CT
$712,431Andrew Karellas · University Of Arizona · R01 · FY2021 · CA
GENERAL CLINICAL RESEARCH CENTER
$712,339University Of Kentucky · M01 · FY2001 · RR
Mechanisms of Ischemic Kidney Injury and Repair
$712,313Joseph Vincent Bonventre · Brigham And Women'S Hospital · R01 · FY2024 · DK
Novel Markers for Disease Outcome in Breast Cancer
$712,287Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$712,278Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
The Role of Fgf Signaling in Vertebrate Development
$712,253Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)AWARD OF TASK ORDER "OPTIMIZATION AND FURTHER DEVELOPMENT OF MESOTHELIN VACCINE FOR THE PREVENTION OF OVARIAN CANCER"
$712,240Nathalie Scholler · Sri International · N01 · FY2016 · CA
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
$712,200Karen J Wernli · Kaiser Foundation Research Institute · R01 · FY2021 · CA
Center for Development of Medications and Biologics for Treatment of the Pregnant Patient and Fetus
$712,148Gary D Hankins · University Of Texas Med Br Galveston · U54 · FY2015 · HD
Human natural killer cells: Advancing biology and clinical applications
$712,108Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2019 · CA